期刊
IMMUNITY
卷 24, 期 1, 页码 29-39出版社
CELL PRESS
DOI: 10.1016/j.immuni.2005.12.002
关键词
-
类别
资金
- NATIONAL CANCER INSTITUTE [R21CA107403, R01CA078419, P01CA069381, R01CA067329] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067515] Funding Source: NIH RePORTER
- NCI NIH HHS [CA67329, CA107403, CA078419, CA69381] Funding Source: Medline
- NIDDK NIH HHS [DK067515] Funding Source: Medline
b-catenin has been implicated in thymocyte development because of its function as a coactivator of Tcf/LEF-family transcription factors. Previously, we discovered a novel pathway for p53-induced beta-catenin degradation through a ubiquitin E3 ligase complex involving Siah1, SIP (CacyBP), Skp1, and Ebi. To gain insights into the physiological relevance of this new degradation pathway in vivo, we generated mutant mice lacking SIP. We demonstrate here that SIP-/- thymocytes have an impaired pre-TCR checkpoint with failure of TCR beta gene rearrangement and increased apoptosis, resulting in reduced cellularity of the thymus. Moreover, the degradation of beta-catenin in response to DNA damage is significantly impaired in SIP-/- cells. SIP-/- embryonic fibroblasts show a growth-rate increase resulting from defects in G1 arrest. Thus, the beta-catenin degradation pathway mediated by SIP defines an essential checkpoint for thymocyte development and cell-cycle progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据